TOPIC
BLOOD News & Analysis
Stocks
Fisher & Paykel’s share price has soared as COVID-19 cases rise in Australia, US and Europe, while CSL’s latest acquisition marks another shrewd deal.
Glenn Freeman | 01 July 2020
Stocks
The biotech giant has jumped 22pc a year for the past decade but new players are emerging.
Nicki Bourlioufas | 07 April 2019
Personal Finance
The best books on business, investing and behavioural economics, as chosen by Morningstar.
Emma Rapaport | 14 December 2018